2026 Innovation Roadmap

    2026 Element Biosciences Innovation Roadmap

    What’s coming in 2026

    Scientific progress rarely moves in a straight line. It accelerates when new capabilities fundamentally change what is possible.

    In 2026, Element introduces two major advances designed to remove long-standing constraints in sequencing and multiomics. From a new high-throughput platform to direct spatial sequencing in tissue on AVITI24™, this is a year defined by true acceleration, not incremental change.

    VITARI™

    Scale without the premium

    As studies grow larger, throughput alone isn’t enough. VITARI is designed to deliver throughput while remaining flexible, cost-effective, and easy to use. Researchers can run different projects side by side, start runs as samples are ready, and avoid the delays and inefficiencies of forced batching.

    What this enables

    • Confidently scale experiments with high-quality data
    • Keep instruments productive every day—not just when batches are full
    • Support multiple applications in every run

    Platform highlights

    • Up to 10B reads per run with >90% Q30
    • Lower costs at scale with a $100 genome
    • Flexible right-sized runs with independent dual sides and 6 lanes per flow cell

    Available H2 2026. Pre-order yours today.

    Tissue on AVITI24

    Tissue profiling on AVITI24

    Spatial sequencing without fragmented workflows

    Traditional spatial profiling relies on multiple assays, each offering only part of the story. In 2026, AVITI24 brings Direct In Sample Sequencing to tissue. Built for FFPE and fresh frozen samples, researchers can preserve spatial context while directly linking expressed variant detection to cell state and tissue architecture.

    What this enables

    • See where expressed genetic variants occur with true biological context
    • Resolve cellular architecture in tissues with transcriptomic readouts
    • Generate spatial insight with fast runtimes and simplified workflows

    Capability highlights

    • High-specificity direct spatial sequencing with alignment-based confidence
    • Up to 20 cm² of imageable tissue area per dual-sided run
    • Post-run H&E compatibility on the same sample

    Available in H2 2026.

    Subscribe for innovation updates

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.